The Amniotic Membranes segment is expected to reach US$1.2 Billion by 2030 with a CAGR of a 8.4%. The Amniotic Suspensions segment is also set to gro ...

Russell Regional Hospital announces Dr. Tyrel Somers is now a Certified Wound Specialist. He recently completed the rigorous ...

Market Growth: The global decubitus ulcer treatment products market is expected to grow at a 5.5% CAGR, reaching USD 8.5 ...

The State of Israel has submitted a detailed report to Ms. Alice J. Edwards, the United Nations Special Rapporteur on torture ...

Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase II drugs for Diabetic Foot Ulcers does not have sufficient ...

Tigilanol tiglate is under clinical development by QBiotics Group and currently in Phase I for Adenocarcinoma.